On July 26, Algimed Techno successfully passed the supervisory audit according to the international standard and confirmed the certificates ISO 9001:2015 and ISO 13485:2016.
«Algimed Techno» successfully and dynamically develops. We have grown from a small laboratory to one of the leading scientific and biotechnological manufacturers in just 4 years. To ensure an effective increase in the production volume, it is time to modernize laboratories, expand administrative and production parts, as well as warehouse.
On June 14, 2023, in Baku, more than 100 specialists from Azerbaijan, Turkey, Croatia, Belarus and Russia took part in a conference dedicated to droplet PCR research and its application in science and diagnostics. The main goal of the event organizer Bayramli Group was to emphasize the importance of developing molecular technologies in Azerbaijan and Western Asia, as they provide new opportunities for research and diagnosis of infections, detection of single tumor cells, viral load assessment in food safety and vaccine production.
Algimed Techno – manufacturer of NOVAprep® Equipment and Reagents for Liquid-Based Cytology supports the prevention, detection and treatment of cervical cancer. “ No woman should die from a preventable disease. Elimination of cervical cancer is within our grasp if we unite behind this common goal and deliver vaccination, screening and treatment. ” Dr Nino Berdzuli, Director of Country Health Programmes, WHO Regional Office for Europe.
We are glad to present our own product – Deep Well Plate (96 wells)! The Deep Well Plate is recommended for use when high chemical resistance, reduced sample binding, centrifugation, long term storage or use at extreme temperatures are required.
On June 2, 2022 Algimed Techno successfully passed the registration and received the certificate of conformity for IgGRBD-SARS-CoV-2 ELISA kit. The kit have been granted CE-IVD status, according to Directive 98/79/EC of the European Parliament on the treatment of medical products, thereby confirming compliance with all European Union acts and standards, its quality and safety for health.
NOVAprep® is a comprehensive solution for diagnosing oncological diseases of various localizations and screening women for cervical cancer. NOVAprep® has been granted CE-IVD status under Directive 98/79/EC of the European Parliament on in vitro diagnostic medical devices, which confirms the safety of NOVAprep® medical products and equipment and compliance with European Union quality standards.